癌症生物学与医学(英文版)杂志是什么级别的期刊？

H2：Introduction to Cancer Biology and MedicineCancer Biology and Medicine (CBM) is an international peer-reviewed open-access journal that is published by the Chinese Anti-Cancer Association. The journal was first launched in 2004 and has achieved significant growth over the years, with the acceptance rates of submitted papers increasing from approximately 25% in 2017 to 40% in 2021. Moreover, CBM is indexed in several prominent databases, including PubMed, PubMed Central, and Web of Science.H2: Editorial Policy and ScopeCBM mainly focuses on covering research related to cancer biology and medicine from various perspectives such as genetics, immunology, pharmacology, oncology, and clinical medicine. The journal aims to provide a platform for researchers, clinicians, and policymakers to share and discuss their findings and ideas regarding cancer. Additionally, CBM recognizes the significance of translational research and encourages the submission of papers with clinical implications.H2: Review of CBMCBM has proven to be a reputable journal, with a high impact factor of 4.87 in 2021, ranking at the 68th percentile in the Oncology category according to Journal Citation Reports. The journal has published numerous high-quality papers, including basic research on tumor biomarkers and mechanisms of malignancy, clinical research on cancer treatment and diagnosis, and translational research on novel therapies and cancer prevention strategies.However, the journal also faces some criticism. Some researchers have reported excessively long review times and a lack of clarity and consistency in the review process. Additionally, the journal does not have a systematic protocol for handling potential conflicts of interest or promoting ethical practices.H2: Submission GuidelinesCBM accepts original research articles, reviews, perspectives, and short communications. All submissions must be written in English and should follow the journal's formatting guidelines available on its website. The journal employs a double-blind peer-review process, and the average length of the review process is approximately 60 days.Authors are required to comply with the ethical guidelines presented in the Uniform Requirements for Manuscripts Submitted to Biomedical Journals established by the International Committee of Medical Journal Editors. Furthermore, authors must disclose any conflicts of interest and share their data and materials upon request.H2: ConclusionCancer Biology and Medicine is a highly regarded journal with a considerable impact factor in the oncology category. The journal provides a forum for researchers and clinicians to contribute new knowledge and therapeutic strategies to cancer biology and medicine. CBM maintains a rigorous review process and follows ethical guidelines and submission requirements. However, the journal's review timeline is a concern for some authors. Overall, CBM is an excellent resource for those interested in the field of cancer research and medicine.